These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Modification of personality changes in epileptics using dipropylacetate (Convulex). Preliminary communication]. Deisenhammer E Wien Med Wochenschr; 1977 Jun; 127(12):370-3. PubMed ID: 333779 [No Abstract] [Full Text] [Related]
5. [Therapeutic results with sodium dipropylacetate in infantile myoclonus epilepsy]. Papini M; Martinetti MG; Guerri S; Pasquinelli A Riv Neurol; 1976; 46(6):503-7. PubMed ID: 827804 [No Abstract] [Full Text] [Related]
6. [Combined suxilep-depakine (dipropylacetate) therapy in children with suxilep-resistant pyknolepsy]. Todt H; Wünsche W; Korth G Kinderarztl Prax; 1977 Apr; 45(4):175-6. PubMed ID: 406476 [No Abstract] [Full Text] [Related]
7. [Effectiveness of ergenyl (dipropylacetate) in hypsarrhythmia]. Rohmann E; Arndt R Kinderarztl Prax; 1976 Mar; 44(3):109-13. PubMed ID: 775170 [No Abstract] [Full Text] [Related]
8. Sodium valproate in chorea. Br Med J; 1976 Dec; 2(6051):1562. PubMed ID: 137765 [No Abstract] [Full Text] [Related]
9. [Sodium di-n-propylacetate, effect in the treatment of resistant epilepsy. A controlled study]. Gram L; Wulff K; Rasmussen KE; Flachs H; Würtz-Jørgensen A; Sommerbeck KW; Løhren V Ugeskr Laeger; 1977 May; 139(18):1064-9. PubMed ID: 324058 [No Abstract] [Full Text] [Related]
10. Proceedings: Sodium valproate (Epilim) and photosensitivity. A preliminary report. Herrick CE; Maheshwari MC Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51735 [No Abstract] [Full Text] [Related]
11. Valproic acid and sodium valproate approved for use in epilepsy. FDA Drug Bull; 1978; 8(2):14-5. PubMed ID: 344120 [No Abstract] [Full Text] [Related]
12. [Transient Parkinson syndrome and tremor caused by the use of sodium valproate]. van der Zwan A Ned Tijdschr Geneeskd; 1989 Jun; 133(24):1230-2. PubMed ID: 2501690 [TBL] [Abstract][Full Text] [Related]
13. Proceedings: Sodium valproate (Epilim) in the treatment of intractable epilepsy, including some observations on blood levels. Scott DF; Lloyd MH; France M; Hamilton C; Cohne RD Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51736 [No Abstract] [Full Text] [Related]
14. The prevention of ethanol withdrawal seizures in rats by dipropylacetate. Hillbom ME Neuropharmacology; 1975 Oct; 14(10):755-61. PubMed ID: 1105231 [No Abstract] [Full Text] [Related]
15. [Sodium dipropyl acetate in the prevention of febrile convulsions in children]. Galli V; Gatti G; Massolo F; Nalin A; Rozzi N; Tamborino G Acta Neurol (Napoli); 1977; 32(6):884-91. PubMed ID: 343515 [No Abstract] [Full Text] [Related]
16. Progressive myoclonic epilepsy. The response to sodium di -- n -- propylacetate. Tomlinson EB Proc Aust Assoc Neurol; 1974; 11():203-8. PubMed ID: 4620029 [No Abstract] [Full Text] [Related]
17. Sodium valproate: a new anticonvulsant. Med Lett Drugs Ther; 1977 Nov; 19(23):93-4. PubMed ID: 337093 [No Abstract] [Full Text] [Related]
18. Sodium valproate (Epilim) in the treatment of refractory epilepsy. Lines DR N Z Med J; 1978 Jan; 87(603):9-12. PubMed ID: 347342 [TBL] [Abstract][Full Text] [Related]
19. Proceedings: The effect of sodium valproate (Epilim) on the EEG. Maheshwari MC; Jeavons PM Electroencephalogr Clin Neurophysiol; 1975 Oct; 39(4):429. PubMed ID: 51737 [No Abstract] [Full Text] [Related]